Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 1Nausea 1Inflammation 1Colorectal Neoplasms 1

Interventions

Palonosetron 13Aprepitant 13Dexamethasone 11Ondansetron 10fosaprepitant 4Olanzapine 4Granisetron 3Calcium Dobesilate 3ramosetron 2netupitant 2Tropisetron 2Radiotherapy 2Fluorouracil 2rolapitant 1netupitant, palosentron drug combination 1ginger extract 1dolasetron 1casopitant 1Yoga 1Therapeutics 1Serotonin 5-HT3 Receptor Antagonists 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiation 1Pantoprazole 1Paclitaxel 1Oxaliplatin 1Octreotide 1Megestrol Acetate 1Megestrol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Vomiting × ginger extract × Clear all
NCT00064272 2016-10-21

IRB 2003-551

University of Michigan Rogel Cancer Center

Phase 2 Completed
180 enrolled

Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡